MAB PHARM
Reliance Life Sciences ends deal with Epirus for Remicade copiesJanssen’s Remicade is the third biggest pharmaceutical brand globally with sales exceeding $8 billion last year.- Cipla earmarks $65 m to buy stakes in 2 cosThe drug maker will acquire 40% in Goa's Mab Pharm & 25% in Shanghai's Bio Mabs.
- Load More